RARE DISEASES A–Z · LETTER I

Immune Thrombocytopenia

Immune thrombocytopenia (ITP) is an autoimmune condition in which the immune system destroys platelets — the tiny blood fragments that seal leaks — and slows their production. The result is a low platelet count and a tendency to bruise and bleed from skin and mucous membranes.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.

In short: Immune thrombocytopenia (ITP) is an autoimmune platelet shortage causing bruising, pinpoint skin bleeds, and gum bleeding — but often no symptoms at all. Treatment, when needed, ranges from steroids to platelet-boosting medicines; many people are just monitored.

The guide

The basics

Platelets are the cell fragments that plug leaks in blood vessels. In ITP the immune system marks them for destruction — mainly in the spleen — and also suppresses their production in the marrow, so the count falls from a normal 150,000–400,000 per microlitre to sometimes under 10,000. The bleeding pattern is skin-deep: petechiae (pinpoint red spots that do not blanch), easy bruising, bleeding gums, nosebleeds, blood blisters in the mouth, and heavy periods. Deep muscle and joint bleeds — the hemophilia pattern — do not occur, and serious internal bleeding is uncommon but is the feared complication, especially in older patients. ITP can follow a viral illness (typical in children, who usually recover), accompany other autoimmune conditions, or appear on its own in adults, where it often becomes long-term.

How it works

ITP is a diagnosis of exclusion: there is no single confirmatory test. A blood count shows isolated low platelets with normal red and white cells, and the blood film shows genuinely few (often large, young) platelets without abnormal cells. Tests exclude the impostors — liver disease, an enlarged spleen trapping platelets, bone marrow disorders, leukaemia, lupus and other autoimmune disease, HIV and hepatitis C, and medicines such as heparin or quinine. Anti-platelet antibody tests are too unreliable to decide the diagnosis. Bone marrow examination is reserved for atypical cases, older patients, or before spleen removal. The platelet count alone does not dictate treatment — bleeding symptoms and the person's circumstances matter as much.

Day to day

Treatment aims for a safe platelet count, not a normal one. When treatment is needed — because of bleeding, very low counts, or an upcoming procedure — first-line therapy is a short course of corticosteroids, with intravenous immunoglobulin added when a rapid rise is needed (for example, before surgery or with significant bleeding). For persistent disease, the main options are thrombopoietin receptor agonists — tablets or weekly injections that drive the marrow to make more platelets, effective in most people while taken — and rituximab, an antibody treatment that can produce lasting remission in some. Splenectomy, the oldest durable option, is now usually deferred for a year or more while medical therapies are tried. Platelet transfusion is reserved for serious bleeding, since transfused platelets are destroyed quickly.

When to get help

Reviews track the count, bleeding symptoms, and treatment side effects. Know your personal bleeding plan: which symptoms mean 'call today' (new blood blisters in the mouth, blood in urine, black stools, a severe headache, a heavy head injury) and which mean routine review. Avoid medicines that impair platelet function — aspirin and anti-inflammatory painkillers — unless your team agrees, and tell dentists and surgeons about the diagnosis before procedures so platelet cover can be planned. Vaccination after any spleen removal, and prompt treatment of infections, are part of long-term care. Many adults with stable counts and no bleeding are simply monitored, which is a legitimate, evidence-based plan.

See a doctor promptly if: A severe or unusual headache, vomiting, blood in urine or vomit, black stools, or a head injury with a low platelet count needs emergency assessment — internal bleeding must be excluded.

Common questions

Why are there so many names for ITP?

Immune thrombocytopenia — the name was updated from 'idiopathic thrombocytopenic purpura' because many patients have no purpura (bruising rash), and the immune mechanism is understood. You will still see ITP used for all three versions of the name.

My platelet count is very low but I feel fine — is that possible?

Not usually. A low platelet count raises bleeding risk, but many people with alarming-looking counts never bleed at all, and serious bleeding is uncommon, particularly in younger patients. Treatment weighs actual bleeding, lifestyle, and planned procedures, not the number alone.

Will I need my spleen removed?

Removing the spleen (splenectomy) was the classic durable treatment, because the spleen both destroys platelets and makes the antibody. It still works well for many, but it is irreversible and carries lifelong infection risk, so it is usually deferred a year or more while medical options are tried.

Does ITP go away?

Many children recover completely within months, even without treatment — childhood ITP is often post-viral and self-limiting. Adult ITP is more often chronic, though modern treatments control it well even when it persists.

More in Letter I

Related

This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Platelet thresholds and treatment choices are individual; follow your haematology team's advice and bleeding plan.